LARS anticorps (AA 250-300)

N° du produit ABIN7454577

Détail du produit anti-LARS anticorps

Antigène: LARS (Leucyl-tRNA Synthetase (LARS))

Épitope: AA 250-300

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LARS est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))

Fonction: Rabbit anti-LARS Antibody, Affinity Purified

Homologie: Orangutan

Purification: Affinity Purified

Immunogène: Between AA 250 and 300

Isotype: IgG

Information d'application

Indications d'application:

IHC: 1:500 - 1:2,000. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.

IP: Not recommended

WB: 1:1,000 - 1:5,000

Restrictions: For Research Use only

Stockage

Concentration: 1000 μg/mL

Buffer: Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Date de péremption: 12 months

Détails sur LARS

Antigène: LARS (Leucyl-tRNA Synthetase (LARS))

Autre désignation: LARS (LARS Produits)

Sujet: Background: Leucyl-tRNA synthetase (LARS) catalyzes the specific attachment of an amino acid to its cognate tRNA in a two step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. LARS exhibits a post-transfer editing activity to hydrolyze mischarged tRNAs [taken from the Universal Protein Resource (UniProt) Q9P2J5].

ID gène: 51520

NCBI Accession: NP_064502

UniProt: Q9P2J5

Pathways: EGFR Signaling Pathway